Literature DB >> 24156259

Relationships between white matter hyperintensities, cerebral amyloid angiopathy and dementia in a population-based sample of the oldest old.

M Tanskanen, R N Kalaria, I-L Notkola, M Mäkelä, T Polvikoski, L Myllykangas, R Sulkava, H Kalimo, A Paetau, P Scheltens, F Barkhof, Ecw van Straaten, T Erkinjuntti1.   

Abstract

Previous reports suggest that brain white matter changes, a surrogate for small vessel disease, are related to cerebral amyloid angiopathy (CAA). However, this relationship has not been explored in population-based studies or in the oldest old (>85 years of age). We studied the relationships between white matter hyperintensities (WMH) determined by post-mortem magnetic resonance imaging (MRI) and neuropathologically assessed CAA in demented and nondemented subjects enrolled in the prospective community-based Finnish Vantaa 85+ Study. In this analysis, we evaluated scans and brain samples from 123 subjects (86% women) with a mean age of 90.6 years. We found CAA to be present in 63 % of the 123 subjects, whereas WMH was present in 74%, and dementia in 59 %. The presence of WMH of any severity did not relate to the presence or the degree of CAA severity, irrespective of the dementia status of the subjects. Furthermore, multivariate regression analysis showed a clear association between CAA and dementia but WMH was not related to dementia in this very old sample. We conclude that severe WMH may not be determined by CAA in this very elderly population.

Entities:  

Mesh:

Year:  2013        PMID: 24156259     DOI: 10.2174/15672050113106660177

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  7 in total

Review 1.  Cognitive impairment and risk of future stroke: a systematic review and meta-analysis.

Authors:  Meng Lee; Jeffrey L Saver; Keun-Sik Hong; Yi-Ling Wu; Hsing-Cheng Liu; Neal M Rao; Bruce Ovbiagele
Journal:  CMAJ       Date:  2014-08-25       Impact factor: 8.262

2.  White matter integrity, hippocampal volume, and cognitive performance of a world-famous nonagenarian track-and-field athlete.

Authors:  A Z Burzynska; C N Wong; L Chaddock-Heyman; E A Olson; N P Gothe; A Knecht; M W Voss; E McAuley; A F Kramer
Journal:  Neurocase       Date:  2015-08-03       Impact factor: 0.881

3.  Prevalence of mixed pathologies in the aging brain.

Authors:  Jasmin Rahimi; Gabor G Kovacs
Journal:  Alzheimers Res Ther       Date:  2014-11-21       Impact factor: 6.982

4.  White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration.

Authors:  Benjamin M Kandel; Brian B Avants; James C Gee; Corey T McMillan; Guray Erus; Jimit Doshi; Christos Davatzikos; David A Wolk
Journal:  Alzheimers Dement (Amst)       Date:  2016-04-07

Review 5.  Stroke injury, cognitive impairment and vascular dementia.

Authors:  Raj N Kalaria; Rufus Akinyemi; Masafumi Ihara
Journal:  Biochim Biophys Acta       Date:  2016-01-22

Review 6.  Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease.

Authors:  Raj N Kalaria
Journal:  Acta Neuropathol       Date:  2016-04-09       Impact factor: 17.088

7.  Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.

Authors:  Kirsty E McAleese; Lauren Walker; Sophie Graham; Elisa L J Moya; Mary Johnson; Daniel Erskine; Sean J Colloby; Madhurima Dey; Carmen Martin-Ruiz; John-Paul Taylor; Alan J Thomas; Ian G McKeith; Charles De Carli; Johannes Attems
Journal:  Acta Neuropathol       Date:  2017-06-21       Impact factor: 17.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.